Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis

OBJECTIVE: Infusion reaction is a major adverse event in patients with rheumatoid arthritis (RA) treated with infliximab. The possible factors including Fcγ receptor (FcγR) polymorphism associated with the development of infusion reactions in patients with RA receiving infliximab were prospectively...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Okuyama, Ayumi, Nagasawa, Hayato, Suzuki, Katsuya, Kameda, Hideto, Kondo, Harumi, Amano, Kouichi, Takeuchi, Tsutomu
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2010
Matèries:
Clinical and Epidemiological Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3015102/
https://ncbi.nlm.nih.gov/pubmed/20980704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.136283
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars